Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
Public ClinicalTrials.gov record NCT01466374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether BMS-936557 is effective for the treatment of moderate to severely active Crohn's Disease in patients who have had insufficient response and/or intolerance to conventional therapy for Crohn's Disease.
Study identification
- NCT ID
- NCT01466374
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011
- Primary completion
- May 31, 2014
- Completion
- Nov 30, 2014
- Last update posted
- Oct 11, 2015
2011 – 2014
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern California Medical Gastroenterology Group | Santa Monica | California | 90404 | — |
| Shafran Gasteroenterology Center | Winter Park | Florida | 32789 | — |
| Gastroenterology Research Of New Orleans | Hammond | Louisiana | 70403 | — |
| Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr | Chevy Chase | Maryland | 20815 | — |
| Midwest Center For Clinical Research | Lees Summit | Missouri | 64064 | — |
| Nyu Langone Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| Mount Sinai School Of Medicine | New York | New York | 10029 | — |
| University Of North Carolina At Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Consultants For Clinical Research | Cincinnati | Ohio | 45219 | — |
| Gastroenterology Research Of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01466374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2015 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01466374 live on ClinicalTrials.gov.